Accession Number: | 0000899243-21-025955 |
Date: | 2021-06-23 |
Issuer: | ITERUM THERAPEUTICS PLC (ITRM) |
Original Submission Date: |
AHRENS BRENTON KARL
C/O CANAAN PARTNERS
285 RIVERSIDE AVE., SUITE 250
WESTPORT, CT 06880
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.01 | 2021-06-23 | deemed execution date | A | 64,706 (a) | 2031-06-22 | ordinary shares 64,706 | $2.01 | 64,706 | direct |
ID | footnote |
---|---|
f1 | subject to the reporting person providing continuous service to the issuer and the other terms and conditions of the issuer's amended and restated 2018 equity incentive plan, as amended, the shares subject to this option shall vest in full on june 23, 2022. |